Background
Streptococcus gallolyticus subspecies gallolyticus
(SGG) and
Fusobacterium (F.) nucleatum
have been implicated in colorectal carcinogenesis. Here, the association of immune responses to bacterial exposure with advancing stages of colorectal neoplasia was assessed by multiplex serology.
Methods
Immunoglobulin (Ig) A and G antibody responses to eleven proteins each of
F. nucleatum
and SGG were measured in plasma of controls (
n
= 100) and patients with colorectal cancer (CRC,
n
= 25), advanced adenoma (
n
= 82), or small polyps (
n
= 85). Multivariable logistic regression was used to evaluate the association of bacterial sero-positivity with colorectal neoplasia. In a cohort subset with matched data (
n
= 45),
F. nucleatum
sero-positivity was correlated with bacterial abundance in both neoplastic and matched normal tissue.
Results
IgG sero-positivity to Fn1426 of
F. nucleatum
was associated with an increased CRC risk (OR = 4.84; 95% CI 1.46–16.0), while IgA sero-positivity to any SGG protein or specifically Gallo0272 and Gallo1675 alone was associated with increased advanced adenoma occurrence (OR = 2.02, 95% CI 1.10–3.71; OR = 2.67, 95% CI 1.10–6.46; and OR = 6.17, 95% CI 1.61–23.5, respectively). Only
F. nucleatum
abundance in the normal mucosa positively correlated with the IgA response to the Fn1426 antigen (Correlation coefficient (r) = 0.38,
p
< 0.01).
Conclusion
Antibody responses to SGG and
F. nucleatum
were associated with occurrence of colorectal adenomas and CRC, respectively. Further studies are needed to clarify the role these microbes or the immune response to their antigens may have in colorectal carcinogenesis stages.
Graphical Abstract
Supplementary Information
The online version contains supplementary material available at 10.1007/s10620-023-08001-4.